SentinelOne (S) 10-Q 31 Aug 22 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jul. 31, 2022	Aug. 26, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2022
Document Transition Report	false
Entity File Number	001-40531
Entity Registrant Name	SENTINELONE, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	99-0385461
Entity Address, Address Line One	444 Castro Street, Suite 400
Entity Address, City or Town	Mountain View
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94041
City Area Code	(855)
Local Phone Number	868-3733
Title of 12(b) Security	Class A common stock, par value $0.0001
Trading Symbol	S
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Central Index Key	0001583708
Class A
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		205,756,251
Class B
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		75,159,338

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Current assets:
Cash and cash equivalents	$ 269,493	$ 1,669,304
Short-term investments	949,883	374
Accounts receivable, net	106,380	101,491
Deferred contract acquisition costs, current	30,894	27,546
Prepaid expenses and other current assets	33,348	18,939
Total current assets	1,389,998	1,817,654
Property and equipment, net	33,031	24,918
Operating lease right-of-use assets	25,270	23,884
Deferred contract acquisition costs, non-current	44,429	41,022
Intangible assets, net	159,677	15,807
Goodwill	540,308	108,193
Restricted cash, non-current	64,207	2,747
Other assets	8,174	7,956
Total assets	2,265,094	2,042,181
Current liabilities:
Accounts payable	14,469	9,944
Accrued liabilities	31,913	22,657
Accrued payroll and benefits	38,576	61,150
Operating lease liabilities, current	4,004	4,613
Deferred revenue, current	244,207	182,957
Total current liabilities	333,169	281,321
Deferred revenue, non-current	100,844	79,062
Operating lease liabilities, non-current	25,261	24,467
Other liabilities	66,004	6,543
Total liabilities	525,278	391,393
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock; $0.0001 par value; 50,000,000 shares authorized as of July 31, 2022 and January 31, 2022, and no shares issued and outstanding as of July 31, 2022 and January 31, 2022	0	0
Additional paid-in capital	2,549,614	2,271,980
Accumulated other comprehensive income (loss)	(2,013)	454
Accumulated deficit	(807,813)	(621,673)
Total stockholders’ equity	1,739,816	1,650,788
Total liabilities and stockholders’ equity	2,265,094	2,042,181
Class A
Stockholders’ equity:
Common stock, value, issued	20	16
Class B
Stockholders’ equity:
Common stock, value, issued	$ 8	$ 11

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jul. 31, 2022	Jan. 31, 2022
Preferred stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A
Common stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,500,000,000	1,500,000,000
Common stock, shares, issued (in shares)	205,329,881	162,666,515
Common stock, shares, outstanding (in shares)	205,329,881	162,666,515
Class B
Common stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	300,000,000
Common stock, shares, issued (in shares)	75,246,506	107,785,100
Common stock, shares, outstanding (in shares)	75,246,506	107,785,100

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Statement [Abstract]
Revenue	$ 102,505	$ 45,750	$ 180,760	$ 83,145
Cost of revenue	36,261	18,788	63,400	37,071
Gross profit	66,244	26,962	117,360	46,074
Operating expenses:
Research and development	54,989	31,037	100,870	58,857
Sales and marketing	79,000	40,970	139,641	77,150
General and administrative	40,447	22,110	75,337	38,834
Total operating expenses	174,436	94,117	315,848	174,841
Loss from operations	(108,192)	(67,155)	(198,488)	(128,767)
Interest income	3,222	21	4,309	44
Interest expense	(607)	(479)	(612)	(782)
Other income (expense), net	427	(373)	136	(966)
Loss before provision for income taxes	(105,150)	(67,986)	(194,655)	(130,471)
Provision for income taxes	(8,844)	177	(8,515)	326
Net loss	$ (96,306)	$ (68,163)	$ (186,140)	$ (130,797)
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share)	$ (0.35)	$ (0.57)	$ (0.68)	$ (1.59)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share)	$ (0.35)	$ (0.57)	$ (0.68)	$ (1.59)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	277,417,227	120,520,061	273,424,105	82,394,440
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	277,417,227	120,520,061	273,424,105	82,394,440

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (96,306)	$ (68,163)	$ (186,140)	$ (130,797)
Other comprehensive income (loss):
Change in unrealized losses on investments	(1,230)	0	(2,467)	0
Foreign currency translation adjustments	0	100	0	290
Total comprehensive loss	$ (97,536)	$ (68,063)	$ (188,607)	$ (130,507)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) shares in Thousands, $ in Thousands	Total	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Class A and Class B Common Stock Class A and Class B Common Stock
Shares, beginning of period (in shares) at Jan. 31, 2021	167,058,113
Balance, beginning of period at Jan. 31, 2021	$ 621,139
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	(167,058,113)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	$ (621,139)
Shares, end of period (in shares) at Jul. 31, 2021	0
Balance, end of period at Jul. 31, 2021	$ 0
Shares, beginning of period (in shares) at Jan. 31, 2021					39,242,316
Balance, beginning of period at Jan. 31, 2021	(320,536)	$ 29,869	$ 165	$ (350,572)	$ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)					169,787,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	621,139	621,129			$ 10
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions (in shares)					41,678,568
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions	1,380,960	1,380,956			$ 4
Issuance of common stock upon exercise of stock options (in shares)					4,625,342
Issuance of common stock upon exercise of options	5,827	5,827
Vesting of early exercised stock options	544
Issuance of common stock upon exercise of warrants (in shares)					940,953
Vesting of early exercised stock options	554	554
Issuance of common stock and awards assumed in connection with acquisition (in shares)					7,277,214
Issuance of common stock assumed in connection with acquisition	120,319	120,318			$ 1
Issuance of restricted stock awards (in shares)					1,315,099
Stock-based compensation	37,712	37,712
Issuance of stock for services provided (in shares)					20,000
Issuance of restricted stock for services provided	500	500
Other comprehensive income (loss)	0
Foreign currency translation adjustments	290		290
Net loss	(130,797)			(130,797)
Shares, end of period (in shares) at Jul. 31, 2021					264,886,692
Balance, end of period at Jul. 31, 2021	$ 1,715,968	2,196,865	455	(481,369)	$ 17
Shares, beginning of period (in shares) at Apr. 30, 2021	167,058,113
Balance, beginning of period at Apr. 30, 2021	$ 621,139
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	(167,058,113)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	$ (621,139)
Shares, end of period (in shares) at Jul. 31, 2021	0
Balance, end of period at Jul. 31, 2021	$ 0
Shares, beginning of period (in shares) at Apr. 30, 2021					50,504,590
Balance, beginning of period at Apr. 30, 2021	(245,874)	166,974	355	(413,206)	$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)					169,787,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	621,139	621,129			$ 10
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions (in shares)					41,678,568
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions	1,380,960	1,380,956			$ 4
Issuance of common stock upon exercise of stock options (in shares)					1,975,381
Issuance of common stock upon exercise of options	2,617	2,617
Issuance of common stock upon exercise of warrants (in shares)					940,953
Vesting of early exercised stock options	537	537
Stock-based compensation	24,152	24,152
Issuance of restricted stock for services provided	500	500
Other comprehensive income (loss)	0
Foreign currency translation adjustments	100		100
Net loss	(68,163)			(68,163)
Shares, end of period (in shares) at Jul. 31, 2021					264,886,692
Balance, end of period at Jul. 31, 2021	$ 1,715,968	2,196,865	455	(481,369)	$ 17
Shares, beginning of period (in shares) at Jan. 31, 2022	0
Balance, beginning of period at Jan. 31, 2022	$ 0
Shares, end of period (in shares) at Jul. 31, 2022	0
Balance, end of period at Jul. 31, 2022	$ 0
Shares, beginning of period (in shares) at Jan. 31, 2022					270,451,615
Balance, beginning of period at Jan. 31, 2022	1,650,788	2,271,980	454	(621,673)	$ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					3,369,153
Issuance of common stock upon exercise of options	8,381	8,381
Vesting of restricted stock units (in shares)					317,854
Issuance of common stock under employee purchase plan (in shares)					405,534
Issuance of common stock under employee purchase plan	8,682	8,682
Vesting of early exercised stock options	18	18
Issuance of common stock and awards assumed in connection with acquisition (in shares)					6,032,231
Issuance of common stock assumed in connection with acquisition	186,333	186,332			$ 1
Stock-based compensation	74,221	74,221
Other comprehensive income (loss)	(2,467)		(2,467)
Foreign currency translation adjustments	0
Net loss	(186,140)			(186,140)
Shares, end of period (in shares) at Jul. 31, 2022					280,576,387
Balance, end of period at Jul. 31, 2022	$ 1,739,816	2,549,614	(2,013)	(807,813)	$ 28
Shares, beginning of period (in shares) at Apr. 30, 2022	0
Balance, beginning of period at Apr. 30, 2022	$ 0
Shares, end of period (in shares) at Jul. 31, 2022	0
Balance, end of period at Jul. 31, 2022	$ 0
Shares, beginning of period (in shares) at Apr. 30, 2022					272,496,624
Balance, beginning of period at Apr. 30, 2022	1,597,242	2,309,505	(783)	(711,507)	$ 27
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)					1,350,556
Issuance of common stock upon exercise of options	3,291	3,291
Vesting of restricted stock units (in shares)					291,442
Issuance of common stock under employee purchase plan (in shares)					405,534
Issuance of common stock under employee purchase plan	8,682	8,682
Issuance of common stock and awards assumed in connection with acquisition (in shares)					6,032,231
Issuance of common stock assumed in connection with acquisition	186,333	186,332			$ 1
Stock-based compensation	41,804	41,804
Other comprehensive income (loss)	(1,230)		(1,230)
Foreign currency translation adjustments	0
Net loss	(96,306)			(96,306)
Shares, end of period (in shares) at Jul. 31, 2022					280,576,387
Balance, end of period at Jul. 31, 2022	$ 1,739,816	$ 2,549,614	$ (2,013)	$ (807,813)	$ 28

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (186,140)	$ (130,797)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	10,794	3,637
Amortization of deferred contract acquisition costs	32,532	9,087
Non-cash operating lease costs	1,609	1,408
Stock-based compensation expense	72,631	34,830
Other	(1,619)	105
Changes in operating assets and liabilities, net of effects of acquisition
Accounts receivable	480	(10,339)
Prepaid expenses and other assets	(9,151)	(11,190)
Deferred contract acquisition costs	(39,287)	(16,477)
Accounts payable	6,094	(5,108)
Accrued liabilities	4,148	6,559
Accrued payroll and benefits	(23,669)	6,864
Operating lease liabilities	(2,737)	(1,919)
Deferred revenue	31,285	37,707
Other liabilities	(8,447)	2,842
Net cash used in operating activities	(111,477)	(72,791)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(4,101)	(1,685)
Purchases of intangible assets	(194)	0
Capitalization of internal-use software	(6,028)	(2,852)
Purchases of short-term investments	(1,243,594)	0
Maturities of short-term investments	291,845	0
Cash paid for acquisition, net of cash and restricted cash acquired	(281,032)	(3,449)
Net cash used in investing activities	(1,243,104)	(7,986)
CASH FLOW FROM FINANCING ACTIVITIES:
Payments of deferred offering costs	(186)	(5,068)
Repayment of debt	0	(20,000)
Proceeds from exercise of stock options	8,382	5,827
Proceeds from issuance of common stock under the employee stock purchase plan	8,682	0
Proceeds from initial public offering and private placement, net of underwriting discounts and commissions	0	1,388,563
Net cash provided by financing activities	16,878	1,369,322
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	0	1,146
NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(1,337,703)	1,289,691
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–Beginning of period	1,672,051	399,112
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–End of period	334,348	1,688,803
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	8	403
Income taxes paid (refunded), net of payments	(69)	74
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock-based compensation capitalized as internal-use software	1,590	2,882
Property and equipment purchased but not yet paid	836	93
Internal-use software capitalized but not yet paid	383	0
Vesting of early exercised stock options	18	544
Deferred offering costs accrued but not yet paid	0	2,535
Issuance of common stock and assumed equity awards in connection with acquisition	186,332	120,319
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	$ 0	$ 621,139

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jul. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	ORGANIZATION AND DESCRIPTION OF BUSINESSBusinessSentinelOne, Inc. (SentinelOne, we, our, or us) was incorporated in January 2013 in the State of Delaware. On March 29, 2021, we amended our certificate of incorporation to change our name from Sentinel Labs, Inc. to SentinelOne, Inc. We are a cybersecurity provider that delivers an artificial intelligence-powered platform to enable autonomous cybersecurity defense. Our headquarters is located in Mountain View, California with various other global office locations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP), and applicable rules and regulations of the Securities and Exchange Commission, (SEC), regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022 filed with the SEC on April 7, 2022. In management’s opinion, the accompanying unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which reflect all normal recurring adjustments necessary to present fairly the results for the interim periods, but are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. Principles of Consolidation The condensed consolidated financial statements include the accounts of SentinelOne and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our condensed consolidated financial statements. There have been no material changes in our use of estimates during the six months ended July 31, 2022, as compared to the use of estimates disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022 filed with the SEC on April 7, 2022. Significant Accounting Policies There have been no material changes to our significant accounting policies as compared to the significant accounting policies described in our Annual Report on Form 10-K filed with the SEC on April 7, 2022. Segment and Geographic Information We have a single operating and reportable segment. Our chief operating decision maker (CODM) is our Chief Executive Officer. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and assessing financial performance. For information regarding our revenue by geography, see Note 3. Cash, Cash Equivalents, and Restricted Cash The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the condensed consolidated statements of cash flows (in thousands): As of July 31, As of January 31 2022 2022 Cash and cash equivalents $ 269,493 $ 1,669,304 Restricted cash, current 648 — Restricted cash, non-current 64,207 2,747 $ 334,348 $ 1,672,051 Recently Adopted Accounting Pronouncement s In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer

Revenue and Contract Balances

Revenue and Contract Balances	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue and Contract Balances	REVENUE AND CONTRACT BALANCES Disaggregation of Revenue The following table summarizes revenue by geography based on the shipping address of end customers for the periods presented (in thousands, except percentages): Three Months Ended July 31, 2022 Three Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue United States $ 68,392 67 % $ 31,207 68 % International 34,113 33 14,543 32 Total $ 102,505 100 % $ 45,750 100 % Six Months Ended July 31, 2022 Six Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue United States $ 120,948 67 % $ 57,383 69 % International 59,812 33 25,762 31 Total $ 180,760 100 % $ 83,145 100 % No single country other than the United States represented 10% or more of our revenue during the three and six months ended July 31, 2022 and 2021. The following table summarizes revenue by sales channel for the periods presented (in thousands, except percentages): Three Months Ended July 31, 2022 Three Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue Channel partners $ 92,785 91 % $ 42,126 92 % Direct customers 9,720 9 3,624 8 Total $ 102,505 100 % $ 45,750 100 % Six Months Ended July 31, 2022 Six Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue Channel partners $ 164,237 91 % $ 76,238 92 % Direct customers 16,523 9 6,907 8 Total $ 180,760 100 % $ 83,145 100 % Contract Balances Contract assets consist of unbilled accounts receivable, which arise when a right to consideration for our performance under the customer contract occurs before invoicing the customer. The amount of unbilled accounts receivable included within accounts receivable, net on the condensed consolidated balance sheets was $7.1 million and $1.5 million as of July 31, 2022 and January 31, 2022, respectively. Contract liabilities consist of deferred revenue, which represents invoices billed in advance of performance under a contract. Deferred revenue is recognized as revenue over the contractual period. The deferred revenue balance was $345.1 million and $262.0 million as of July 31, 2022 and January 31, 2022, respectively. We recognized revenue of $55.4 million and $24.5 million during the three months ended July 31, 2022 and 2021, respectively, and $115.4 million and $53.6 million during the six months ended July 31, 2022 and 2021, respectively, that was included in the corresponding contract liability balance at the beginning of the period. Remaining Performance Obligations Our contracts with customers typically range from one As of July 31, 2022, our remaining performance obligations were $444.7 million, of which we expect to recognize 84% as revenue over the next 24 months, with the remainder to be recognized thereafter. We periodically review deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. We did not recognize any impairment of deferred contract acquisition costs during the three and six months ended July 31, 2022 and 2021.

Cash and Cash Equivalents, Inve

Cash and Cash Equivalents, Investments and Fair Value Measurements	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Cash and Cash Equivalents, Investments and Fair Value Measurements	CASH AND CASH EQUIVALENTS, INVESTMENTS, AND FAIR VALUE MEASUREMENTS The following table summarizes information about our cash and cash equivalents, and short-term investments by investment category (in thousands): As of July 31, 2022 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash $ 34,662 $ — $ — $ 34,662 Money market funds Level 1 224,854 — — 224,854 Corporate notes and bonds Level 2 5,001 — (2) 4,999 U.S. agency securities Level 2 4,982 — (4) 4,978 Total cash and cash equivalents $ 269,499 $ — $ (6) $ 269,493 Short-term investments: — Commercial paper Level 2 452,520 — (1,278) 451,242 Corporate notes and bonds Level 2 34,276 — (168) 34,108 U.S. agency securities Level 2 91,380 4 (309) 91,075 U.S. Treasury securities Level 1 374,167 37 (746) 373,458 Total short-term investments $ 952,343 $ 41 $ (2,501) $ 949,883 Liabilities Other liabilities Indemnity Escrow Level 2 $ 61,264 $ — $ (3,022) 1 $ 58,242 Total other liabilities $ 61,264 $ — $ (3,022) $ 58,242 _______________________ (1) Represents imputed interest As of July 31, 2022, we determined that the declines in the market value of our investment portfolio were not driven by credit related factors. During the three and six months ended July 31, 2022 and 2021, we did not recognize any losses on our investments due to credit related factors. As of July 31, 2022, the aggregate fair value of our cash equivalents and short-term investments approximated amortized cost and, as such, there were no unrealized gains or losses, either individually or in the aggregate. The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): As of January 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 1,641,642 $ — $ — $ 1,641,642 Short-term investments: Certificates of deposit — 374 — 374 Total assets measured and recorded at fair value $ 1,641,642 $ 374 $ — $ 1,642,016

Acquisitions

Acquisitions	6 Months Ended
	Jul. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	ACQUISITIONS On May 3, 2022, we acquired 100% of the issued and outstanding equity securities (the Acquisition) of Attivo Networks, Inc. (Attivo), an identity security and lateral movement protection company. Attivo expands our coverage of critical attack surfaces. Identity is an adjacent security solution that complements our core endpoint solution. The Acquisition closed on May 3, 2022 and has been accounted for as a business combination in accordance with ASC Topic 805, Business Combinations . We had post-combination expense with a fair value of $32.9 million that was not included in the total purchase consideration, which is comprised of 307,396 of restricted common stock with an aggregate fair value of $10.0 million, and 378,828 assumed options with an aggregate fair value of $11.5 million. Restricted common stock and assumed options will be recognized as stock-based compensation expense. In addition, in connection with the acquisition, certain employees who were promised compensation related to their previous employment agreements will be paid $11.4 million in cash based on continued employment which will be recognized on a straight-line basis as acquisition-related compensation costs. All post-combination expense is expected to be recognized through May 2026. Post-combination compensation expense is subject to adjustment based on continuing service obligations to the Company of certain stockholders of Attivo. In connection with the Acquisition, we also granted restricted stock units (RSUs) and performance share units (PSUs) under our 2021 Equity Incentive Plan. For further details refer to Note 7. Stock-Based Compensation. The following table presents the preliminary allocation of purchase consideration recorded on our condensed consolidated balance sheet as of the acquisition date (in thousands): Amount Consideration Cash $ 348,917 Common Stock (6,032,231 shares) (1) 185,885 Fair value of total consideration transferred $ 534,802 Cash and cash equivalents $ 8,836 Accounts receivable 4,867 Prepaid expense and other current assets 3,880 Operating lease right-of-use assets 260 Intangible assets 151,900 Accrued liabilities (4,270) Accrued payroll and benefits (1,113) Operating lease liabilities (259) Deferred revenue (51,746) Other liabilities (2,357) Deferred tax liability (7,310) Total identifiable net assets 102,688 Goodwill 432,114 Total purchase consideration $ 534,802 (1) Consideration calculated using the fair value of the Company’s common stock The estimates and assumptions regarding the fair value of certain tangible assets acquired and liabilities assumed, the valuation of intangible assets acquired, income taxes, and goodwill are subject to change as we obtain additional information during the measurement period, which usually lasts for up to one year from the acquisition date. The excess of the purchase price over the fair value of net tangible and intangible assets acquired has been assigned to goodwill. Goodwill represents the future benefits resulting from the acquisition that will enhance the value of our product for both new and existing customers and strengthen our competitive position. Goodwill is not deductible for tax purposes. The following table sets forth the preliminary amounts allocated to the intangible assets identified and their estimated useful lives as of the date of acquisition: Fair Value Useful Life (in thousands) (in years) Customer relationships $ 77,600 10 Developed technology 63,200 5 Backlog 11,100 2 Total intangible assets acquired $ 151,900 The preliminary fair value assigned to customer relationships was determined using the multi-period excess earnings method of the income approach. The fair value assigned to developed technology was determined using the relief from royalty method under the income approach. The fair value assigned to backlog was determined using the multi-period excess earnings method of the income approach. The intangible assets acquired are expected to be amortized over their useful lives on a straight-line basis. Aside from $61.0 million, net, within restricted cash on the condensed consolidated balance sheet, held in an indemnity escrow expected to be paid out within 15 months of the Acquisition, there are no other contingent consideration or cash consideration expected to be paid out subsequent to the Acquisition. The indemnity escrow is carried at fair value within other liabilities in our condensed consolidated balance sheet. The results of operations of Attivo have been included in our condensed consolidated financial statements from the date of the Acquisition. We have incurred $3.3 million and $5.5 million of transaction expenses in connection with the Acquisition during the three and six months ended July 31, 2022, respectively. $1.0 million and $3.2 million of these costs were recorded as general and administrative expenses in our condensed consolidated statements of operations during the three and six months ended July 31, 2022, respectively, with the remainder allocated to purchase price consideration. Our consolidated statements of operations from the date of the Acquisition to the period ended July 31, 2022 includes revenue and net loss of Attivo of $9.3 million and $(9.3) million, respectively. The following unaudited supplemental pro forma financial information is provided for informational purposes only and summarizes our combined results of operations as if the Acquisition occurred on February 1, 2021 (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Revenue $ 102,706 $ 52,741 $ 188,264 $ 96,279 Net loss $ (100,853) $ (82,240) $ (208,032) $ (154,714) The unaudited supplemental pro forma results reflect certain adjustments for the amortization of acquired intangible assets, recognition of stock-based compensation, acquisition-related transaction expenses, and acquisition-related compensation costs. Such pro forma amounts are not necessarily indicative of the results that actually would have occurred had the Acquisition been completed on the date indicated, nor is it indicative of our future operating results.

Intangible Assets

Intangible Assets	6 Months Ended
	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	INTANGIBLE ASSETS Intangible assets, net consisted of the following (in thousands): As of July 31, As of January 31, 2022 2022 Developed technology $ 78,700 $ 15,500 Customer relationship 79,100 1,500 Backlog 11,100 — Non-compete agreements 650 650 Trademarks 150 150 Patents 1,288 1,094 Total finite-lived intangible assets 170,988 18,894 Accumulated amortization - developed technology (6,447) (2,165) Accumulated amortization - customer relationship (3,060) (734) Accumulated amortization - backlog (1,397) — Accumulated amortization - non-compete agreements (319) (212) Accumulated amortization - trademarks (111) (73) Accumulated amortization - patents (232) (158) Less: total accumulated amortization (11,566) (3,342) Total finite-lived intangible assets, net $ 159,422 $ 15,552 Indefinite-lived intangible assets - domain names 255 255 Total intangible assets, net $ 159,677 $ 15,807 Amortization expense of intangible assets was $7.3 million and $0.9 million for the three months ended July 31, 2022 and 2021, respectively, and $8.0 million and $1.6 million for the six months ended July 31, 2022 and 2021, respectively. As of July 31, 2022, estimated future amortization expense is as follows (in thousands): Fiscal Year Ending January 31, Remainder of 2023 $ 14,788 2024 28,532 2025 24,187 2026 22,753 2027 22,753 Thereafter 46,409 Total $ 159,422

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jul. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	STOCK-BASED COMPENSATION Stock-Based Compensation Expense The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Cost of revenue $ 2,399 $ 840 $ 4,247 $ 1,223 Research and development 13,495 8,823 23,958 15,962 Sales and marketing 9,715 3,905 16,811 5,952 General and administrative 15,392 7,825 27,615 11,693 Total $ 41,001 $ 21,393 $ 72,631 $ 34,830 Restricted Stock Units A summary of our RSU activity is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2022 1,770,304 $ 52.51 Granted 7,464,181 $ 33.76 Released (317,854) $ 40.74 Forfeited (214,093) $ 42.51 Outstanding as of July 31, 2022 8,702,538 $ 37.12 As of July 31, 2022, we had unrecognized stock-based compensation expense related to unvested RSUs of $289.3 million that is expected to be recognized on ratably over a weighted-average period of 3.4 years. Stock Options A summary of our stock option activity is as follows: Number of Options Weighted-Average Exercise Price Outstanding as of January 31, 2022 42,422,473 $ 4.30 Granted — $ — Exercised (3,369,153) $ 2.49 Forfeited (717,964) $ 5.40 Assumed options from Attivo acquisition 378,828 $ 1.31 Outstanding as of July 31, 2022 38,714,184 $ 4.41 Expected to vest as of July 31, 2022 38,714,184 $ 4.41 Vested and exercisable as of July 31, 2022 20,030,216 $ 3.04 As of July 31, 2022, we had unrecognized stock-based compensation expense related to unvested options of $134.1 million that is expected to be recognized on ratably over a weighted-average period of 2.4 years. Milestone Options In March 2021, we granted options to purchase 1,404,605 shares of Class B common stock subject to service-based, performance-based, and market-based vesting conditions to our Chief Executive Officer and Chief Financial Officer under the 2013 Plan. These stock options will vest 100% upon the occurrence of our initial public offering (IPO) (the performance-based vesting condition) and the achievement of certain milestone events and our share price targets (the market-based vesting conditions), subject to the executive’s continued service to us from the grant date through the milestone events. For these options, we used a Monte Carlo simulation to determine the fair value at the grant date and the implied service period. During the three and six months ended July 31, 2022, we recorded $0.9 million and $1.8 million, respectively, of stock-based compensation expense related to these milestone options. During the three and six months ended July 31, 2021, we recorded $1.2 million of stock-based compensation expense. As of July 31, 2022, we had unrecognized stock-based compensation expense related to these milestone options of $14.5 million that is expected to be recognized over the remaining vesting period of 4.1 years. Performance Share Units In connection with the acquisition of Attivo, we granted 71,003 shares of performance share units (PSUs) subject to service-based and performance-based vesting conditions. These PSUs will vest 100% upon the achievement of certain financial performance and integration milestone events, subject to the employees’ continued service to us from the grant date through the milestone events or target dates. During the three and six months ended July 31, 2022, we recorded $0.2 million of stock-based compensation expense related to these PSUs. As of July 31, 2022, we had unrecognized stock-based compensation expense related to these PSUs of $1.4 million that is expected to be recognized over the remaining vesting period of 1.4 years. Restricted Common Stock In connection with the acquisition of Attivo, restricted common stock was issued to Attivo employees. See Note 5, Acquisitions , in the notes to our condensed consolidated financial statements for more information regarding these restricted common stock. In connection with the acquisition of Scalyr, Inc. (Scalyr), we issued 1,315,099 shares of restricted common stock with a fair value of $14.59 per share at the time of grant, that vest over a period of two years. During the three and six months ended July 31, 2022, we recorded $2.1 million and $4.2 million, respectively, of stock-based compensation expense related to restricted common stock in connection with our acquisition of Scalyr. During the three and six ended July 31, 2021, we recorded $3.1 million and $5.5 million, respectively, of stock-based compensation expense. As of July 31, 2022, we had unrecognized stock-based compensation expense related to this restricted common stock of $4.4 million that is expected to be recognized over the remaining vesting period of 0.5 years. Employee Stock Purchase Plan (ESPP) The Company recognized stock-based compensation expense related to ESPP of $3.8 million and $6.5 million, respectively, during the three and six months ended July 31, 2022. The Company recognized stock-based compensation expense related to ESPP of $1.0 million during both the three and six months ended July 31, 2021. During the three months ended July 31, 2022 we recorded $0.2 million in expense related to modification of our ESPP as a result of the decrease in our stock price which triggered a reset of the ESPP offering period in accordance with our plan. We expect to record a total of $1.3 million in expense related to this modification through the second quarter of 2024. Attivo Acquisition In connection with the Acquisition, we granted 539,795 shares of restricted stock units (RSUs) under our 2021 Equity Incentive Plan that will vest over a period of 3 years contingent on continued employment of certain Attivo employees, for which stock-based compensation expense will be recognized ratably over the vesting period. Attivo Equity Incentive Plan In connection with our acquisition of Attivo Networks which closed in May 2022, we assumed unvested stock options that were granted under the Attivo 2011 Equity Incentive Plan ("Attivo Plan"). We do not intend to grant any additional shares under the Attivo Plan and the Attivo Plan will continue to govern the terms and conditions of the outstanding awards previously granted thereunder. Any shares underlying stock options that are expired,

Income Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES We compute our tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjusting for discrete items arising in that quarter. We had an effective tax rate of 8.4% and (0.3)% for the three months ended July 31, 2022 and 2021, respectively, and 4.4% and (0.2)% for the six months ended July 31, 2022 and 2021, respectively. We have incurred U.S. operating losses and have minimal profits or offsetting loss carryforwards in certain foreign jurisdictions. We compute our tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjusting for discrete items arising in that quarter. In connection with the Attivo business combination, we recorded a net deferred tax liability primarily attributable to identifiable acquired intangibles. This net deferred tax liability is considered an additional source of income to support the realizability of the Company's deferred tax asset, and as a result we released a portion of the valuation allowance and recorded a one-time discrete tax benefit of $9.7 million for the three and six months ended July 31, 2022

Net Loss Per Share Attributable

Net Loss Per Share Attributable To Common Stockholders	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS Basic and diluted net loss per share attributable to common stockholders is computed in conformity with the two-class method required for participating securities. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive common stock equivalents to the extent they are dilutive. For purposes of this calculation, stock options, restricted common stock, RSUs, PSUs, ESPP, and early exercised stock options are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive for all periods presented. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis. Basic and diluted net loss per share attributable to common stockholders was as follows (in thousands, except share and per share data): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Numerator: Net loss attributable to Class A and Class B common stockholders $ (96,306) $ (68,163) $ (186,140) $ (130,797) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 277,417,227 120,520,061 273,424,105 82,394,440 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.35) $ (0.57) $ (0.68) $ (1.59) The following potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive: As of July 31, 2022 2021 Stock options 38,316,073 48,385,470 Shares subject to repurchase 298,374 63,492 RSUs and PSUs 1,343,582 346,483 ESPP 109,217 85,827 Restricted common stock 405,620 1,315,099 Contingently issuable shares 1,317,079 1,317,079 Total 41,789,945 51,513,450

Commitment and Contingencies

Commitment and Contingencies	6 Months Ended
	Jul. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Legal Contingencies From time to time, we may be a party to various legal proceedings and subject to claims in the ordinary course of business. BlackBerry Litigation Starting in October 2019, BlackBerry Corp. and its subsidiary Cylance, Inc. (BlackBerry) filed a total of nine proceedings (seven lawsuits and two arbitrations) against us and certain former BlackBerry employees who joined our company. In these proceedings, BlackBerry alleges that it has viable legal claims as a result of its former employees joining us. Many of these proceedings have now been dismissed. The status of each of the currently pending proceedings is discussed below. We have defended against these claims and expect to continue to defend against these claims. BlackBerry Corp., et al. v. Coulter, et al. On October 17, 2019, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Coulter, et al., No. 953-10-19 (Vt. Super. Ct.) (Vermont Action) against Chris Coulter, an employee on our Vigilance services team. On October 23, 2019, BlackBerry filed an amended complaint that added us as a defendant. The amended complaint asserts claims against us for conspiracy, tortious interference with contract, aiding and abetting breach of fiduciary duties, and misappropriation of trade secrets. The court entered a preliminary injunction order enjoining Mr. Coulter from working for us through February 2021. As a result of the court’s order, Mr. Coulter chose to seek other employment and is no longer employed by us. On January 15, 2021, the court entered an order narrowing the scope of the case and limiting the claims against us in order to avoid conflict with a similar action that was previously filed in California and was dismissed. The Vermont Action is currently pending. On October 25, 2019, BlackBerry commenced an action captioned BlackBerry Corp., et al v. Coulter, et al., No. 2019-0854-JTL (Del. Ch.) against Mr. Coulter and us in Delaware Chancery Court. The court stayed this case pending resolution of the Vermont Action, and on February 7, 2020, BlackBerry voluntarily dismissed without prejudice all claims against Mr. Coulter and us. On December 3, 2019, BlackBerry initiated a largely duplicative action in arbitration solely against Mr. Coulter administered by JAMS, an alternative dispute resolution provider. That arbitration action, however, was dismissed on or about March 30, 2021, with JAMS informing us that they had closed their files on this matter on April 30, 2021. BlackBerry Corp., et al. v. Page, et al. On November 18, 2019, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Page, et al., No. 2019-CP-07-2552 (S.C. Cir. Ct.) against Barnaby Page, a go-to-market employee, and us, in a South Carolina state court. The complaint asserts claims against us for aiding and abetting breach of fiduciary duties, tortious interference with contract, and misappropriation of trade secrets. Following initial discovery, on August 27, 2020, we and Mr. Page filed a joint motion for judgment on the pleadings. Following initial discovery, the parties agreed to stipulate to a dismissal of this lawsuit without prejudice, and a dismissal order was entered by the court on January 31, 2022. Blackberry Corp. et al. v. Sentinel Labs, Inc., et al. On January 16, 2020, BlackBerry commenced the action captioned, BlackBerry Corp., et al. v. Sentinel Labs, Inc., et al., No. 20CV361950 (Cal. Super. Ct. Santa Clara Cnty.) (Current California Action), against us and unnamed “Doe” defendants, asserting claims against us for trade secret misappropriation and unfair business practices. We filed counterclaims that, in part, seek to invalidate any agreements allegedly supporting BlackBerry’s claims against its former employees. On December 14, 2020, we filed a motion requesting that BlackBerry sufficiently identify any trade secrets it alleges we misappropriated in accordance with California law. On February 12, 2021, the court granted that motion in part, including striking BlackBerry’s expert testimony, and limiting the scope of discovery to customer lists and sales-related information. On March 15, 2021, BlackBerry re-filed a statement identifying its trade secrets to pursue broader claims and discovery. In response, on April 5, 2021, we again filed a motion requesting that BlackBerry sufficiently identify any trade secrets under California law. On June 2, 2021, the court granted the motion in our favor, absent a few discrete areas permitted by the court. On July 2, 2021, Blackberry filed its third amended trade secret identification. In response, on July 16, 2021, we submitted a motion challenging these claims. In its third trade secret statement, in response to our motion again challenging the sufficiency of its trade secret disclosures, Blackberry voluntarily dropped various claims. The parties are currently in the early stages of discovery over the revised trade secret disclosures approved by the court on August 31, 2021. We continue to litigate this action, including actively pursuing our counterclaims against them. BlackBerry Corp., et al. v. Quinn, et al. On February 17, 2020, BlackBerry commenced the action captioned BlackBerry Corp., et al. v. Quinn, et al., No. D-1-GN-20-00096 (Tex. Civ. Ct. – Travis Cnty.) against Sean Quinn, a go-to-market employee, and us, in Texas state court. On August 8, 2020, we and Mr. Quinn moved to stay or dismiss the case in light of the overlapping issues between this case and the Current California Action. On September 21, 2020, the court stayed this case pending resolution of the Current California Action. This lawsuit remains stayed and is pending in abeyance before the Texas court. BlackBerry Corp., et al. v. Kaylan Brown Coulter. On or about April 7, 2022, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Kaylan Brown Coulter, No. 22-cv-01249 (Vt. Super. Ct.) (Brown-Coulter Action) against Kaylan Brown Coulter, the wife of Chris Coulter (referenced above), alleging breach of non-disclosure and non-solicitation agreements, breach of covenant of good faith and fair dealing, breach of fiduciary duties, and civil conspiracy. While this is part of the same series of lawsuits by BlackBerry, we were not named in this action. On May 6, 2022, Ms. Brown-Coulter removed the case to the United States District Court for the District of Vermont, No. 5:22-cv-98 (D. Vt.). Shortly thereafter, on May 13, 2022, Ms. Brown-Coulter filed a motion to dismiss all claims under Federal Rule of Civil Procedure 12(b)(6). This motion is currently pending before the court. We have not recorded any accruals for loss contingencies associated with these legal proceedings, determined that an unfavorable outcome is probable, or determined that the amount or range of any possible loss is reasonably estimable. We believe that there are no other pending or threatened legal proceedings that are likely to have a material adverse effect on our condensed consolidated financial statements. Warranties and Indemnification Our services are generally warranted to deliver and operate in a manner consistent with general industry standards that are reasonably applicable and materially conform with our documentation under normal use and circumstances. Our contracts generally include certain provisions for indemnifying customers against liabilities if our products or services infringe a third party’s intellectual property rights. We also offer a limited warranty to certain customers, subject to certain conditions, to cover certain costs incurred by the customer in case of a cybersecurity breach. We have entered into an insurance policy to cover our potential liability arising from this limited warranty arrangement. We have not incurred any material costs related to such obligations and have not accrued any liabilities related to such obligations in the condensed consolidated financial statements as of July 31, 2022 and January 31, 2022.

Employee Benefit Plan

Employee Benefit Plan	6 Months Ended
	Jul. 31, 2022
Retirement Benefits [Abstract]
Employee Benefit Plan	EMPLOYEE BENEFIT PLAN Our U.S. employees participate in a 401(k) defined contribution plan sponsored by us. Contributions to the plan are discretionary. There were $0.9 million and $1.4 million, respectively, matching contributions for the three and six months ended July 31, 2022, and no matching contributions by us for the three and six months ended July 31, 2021. Israeli Severance Pay Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (Section 14), all of our employees in Israel are entitled to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP), and applicable rules and regulations of the Securities and Exchange Commission, (SEC), regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022 filed with the SEC on April 7, 2022. In management’s opinion, the accompanying unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which reflect all normal recurring adjustments necessary to present fairly the results for the interim periods, but are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of SentinelOne and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. These estimates are based on management’s knowledge about current events and expectations about actions we may undertake in the future. Actual results could differ from these estimates, and such differences could be material to our condensed consolidated financial statements. There have been no material changes in our use of estimates during the six months ended July 31, 2022, as compared to the use of estimates disclosed in our Annual Report on Form 10-K for the fiscal year ended January 31, 2022 filed with the SEC on April 7, 2022. Significant Accounting Policies
Segment and Geographic Information	Segment and Geographic InformationWe have a single operating and reportable segment. Our chief operating decision maker (CODM) is our Chief Executive Officer. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and assessing financial performance.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncement s In October 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jul. 31, 2022
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the condensed consolidated statements of cash flows (in thousands): As of July 31, As of January 31 2022 2022 Cash and cash equivalents $ 269,493 $ 1,669,304 Restricted cash, current 648 — Restricted cash, non-current 64,207 2,747 $ 334,348 $ 1,672,051
Restrictions on Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the condensed consolidated statements of cash flows (in thousands): As of July 31, As of January 31 2022 2022 Cash and cash equivalents $ 269,493 $ 1,669,304 Restricted cash, current 648 — Restricted cash, non-current 64,207 2,747 $ 334,348 $ 1,672,051

Revenue and Contract Balances (

Revenue and Contract Balances (Tables)	6 Months Ended
	Jul. 31, 2022
Revenue from Contract with Customer [Abstract]
Scheduel of Revenue from External Customers by Geographic Areas	The following table summarizes revenue by geography based on the shipping address of end customers for the periods presented (in thousands, except percentages): Three Months Ended July 31, 2022 Three Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue United States $ 68,392 67 % $ 31,207 68 % International 34,113 33 14,543 32 Total $ 102,505 100 % $ 45,750 100 % Six Months Ended July 31, 2022 Six Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue United States $ 120,948 67 % $ 57,383 69 % International 59,812 33 25,762 31 Total $ 180,760 100 % $ 83,145 100 %
Schedule of Disaggregation of Revenue	The following table summarizes revenue by sales channel for the periods presented (in thousands, except percentages): Three Months Ended July 31, 2022 Three Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue Channel partners $ 92,785 91 % $ 42,126 92 % Direct customers 9,720 9 3,624 8 Total $ 102,505 100 % $ 45,750 100 % Six Months Ended July 31, 2022 Six Months Ended July 31, 2021 Amount % of Revenue Amount % of Revenue Channel partners $ 164,237 91 % $ 76,238 92 % Direct customers 16,523 9 6,907 8 Total $ 180,760 100 % $ 83,145 100 %

Cash and Cash Equivalents, In_2

Cash and Cash Equivalents, Investments and Fair Value Measurements (Tables)	6 Months Ended
	Jul. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	The following table summarizes information about our cash and cash equivalents, and short-term investments by investment category (in thousands): As of July 31, 2022 Fair Value Level Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Assets Cash and cash equivalents: Cash $ 34,662 $ — $ — $ 34,662 Money market funds Level 1 224,854 — — 224,854 Corporate notes and bonds Level 2 5,001 — (2) 4,999 U.S. agency securities Level 2 4,982 — (4) 4,978 Total cash and cash equivalents $ 269,499 $ — $ (6) $ 269,493 Short-term investments: — Commercial paper Level 2 452,520 — (1,278) 451,242 Corporate notes and bonds Level 2 34,276 — (168) 34,108 U.S. agency securities Level 2 91,380 4 (309) 91,075 U.S. Treasury securities Level 1 374,167 37 (746) 373,458 Total short-term investments $ 952,343 $ 41 $ (2,501) $ 949,883 Liabilities Other liabilities Indemnity Escrow Level 2 $ 61,264 $ — $ (3,022) 1 $ 58,242 Total other liabilities $ 61,264 $ — $ (3,022) $ 58,242 _______________________ (1) Represents imputed interest The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): As of January 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 1,641,642 $ — $ — $ 1,641,642 Short-term investments: Certificates of deposit — 374 — 374 Total assets measured and recorded at fair value $ 1,641,642 $ 374 $ — $ 1,642,016

Acquisitions (Tables)

Acquisitions (Tables)	6 Months Ended
	Jul. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table presents the preliminary allocation of purchase consideration recorded on our condensed consolidated balance sheet as of the acquisition date (in thousands): Amount Consideration Cash $ 348,917 Common Stock (6,032,231 shares) (1) 185,885 Fair value of total consideration transferred $ 534,802 Cash and cash equivalents $ 8,836 Accounts receivable 4,867 Prepaid expense and other current assets 3,880 Operating lease right-of-use assets 260 Intangible assets 151,900 Accrued liabilities (4,270) Accrued payroll and benefits (1,113) Operating lease liabilities (259) Deferred revenue (51,746) Other liabilities (2,357) Deferred tax liability (7,310) Total identifiable net assets 102,688 Goodwill 432,114 Total purchase consideration $ 534,802 (1) Consideration calculated using the fair value of the Company’s common stock
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The following table sets forth the preliminary amounts allocated to the intangible assets identified and their estimated useful lives as of the date of acquisition: Fair Value Useful Life (in thousands) (in years) Customer relationships $ 77,600 10 Developed technology 63,200 5 Backlog 11,100 2 Total intangible assets acquired $ 151,900
Business Acquisition, Pro Forma Information	The following unaudited supplemental pro forma financial information is provided for informational purposes only and summarizes our combined results of operations as if the Acquisition occurred on February 1, 2021 (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Revenue $ 102,706 $ 52,741 $ 188,264 $ 96,279 Net loss $ (100,853) $ (82,240) $ (208,032) $ (154,714)

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible assets, net consisted of the following (in thousands): As of July 31, As of January 31, 2022 2022 Developed technology $ 78,700 $ 15,500 Customer relationship 79,100 1,500 Backlog 11,100 — Non-compete agreements 650 650 Trademarks 150 150 Patents 1,288 1,094 Total finite-lived intangible assets 170,988 18,894 Accumulated amortization - developed technology (6,447) (2,165) Accumulated amortization - customer relationship (3,060) (734) Accumulated amortization - backlog (1,397) — Accumulated amortization - non-compete agreements (319) (212) Accumulated amortization - trademarks (111) (73) Accumulated amortization - patents (232) (158) Less: total accumulated amortization (11,566) (3,342) Total finite-lived intangible assets, net $ 159,422 $ 15,552 Indefinite-lived intangible assets - domain names 255 255 Total intangible assets, net $ 159,677 $ 15,807
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of July 31, 2022, estimated future amortization expense is as follows (in thousands): Fiscal Year Ending January 31, Remainder of 2023 $ 14,788 2024 28,532 2025 24,187 2026 22,753 2027 22,753 Thereafter 46,409 Total $ 159,422

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jul. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Components of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the condensed consolidated statements of operations consisted of the following (in thousands): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Cost of revenue $ 2,399 $ 840 $ 4,247 $ 1,223 Research and development 13,495 8,823 23,958 15,962 Sales and marketing 9,715 3,905 16,811 5,952 General and administrative 15,392 7,825 27,615 11,693 Total $ 41,001 $ 21,393 $ 72,631 $ 34,830
Schedule of Nonvested Restricted Stock Shares Activity	A summary of our RSU activity is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2022 1,770,304 $ 52.51 Granted 7,464,181 $ 33.76 Released (317,854) $ 40.74 Forfeited (214,093) $ 42.51 Outstanding as of July 31, 2022 8,702,538 $ 37.12
Schedule of Share-based Payment Arrangement, Option, Activity	A summary of our stock option activity is as follows: Number of Options Weighted-Average Exercise Price Outstanding as of January 31, 2022 42,422,473 $ 4.30 Granted — $ — Exercised (3,369,153) $ 2.49 Forfeited (717,964) $ 5.40 Assumed options from Attivo acquisition 378,828 $ 1.31 Outstanding as of July 31, 2022 38,714,184 $ 4.41 Expected to vest as of July 31, 2022 38,714,184 $ 4.41 Vested and exercisable as of July 31, 2022 20,030,216 $ 3.04

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable To Common Stockholders (Tables)	6 Months Ended
	Jul. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Basic and diluted net loss per share attributable to common stockholders was as follows (in thousands, except share and per share data): Three Months Ended July 31, Six Months Ended July 31, 2022 2021 2022 2021 Numerator: Net loss attributable to Class A and Class B common stockholders $ (96,306) $ (68,163) $ (186,140) $ (130,797) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 277,417,227 120,520,061 273,424,105 82,394,440 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.35) $ (0.57) $ (0.68) $ (1.59)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive: As of July 31, 2022 2021 Stock options 38,316,073 48,385,470 Shares subject to repurchase 298,374 63,492 RSUs and PSUs 1,343,582 346,483 ESPP 109,217 85,827 Restricted common stock 405,620 1,315,099 Contingently issuable shares 1,317,079 1,317,079 Total 41,789,945 51,513,450

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022	Jul. 31, 2021	Jan. 31, 2021
Accounting Policies [Abstract]
Cash and cash equivalents	$ 269,493	$ 1,669,304
Restricted cash, current	648	0
Restricted cash, non-current	64,207	2,747
Cash, cash equivalents, restricted cash and restricted cash equivalents	$ 334,348	$ 1,672,051	$ 1,688,803	$ 399,112

Revenue and Contract Balances -

Revenue and Contract Balances - Disaggregation of Revenue by Geography (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 102,505	$ 45,750	$ 180,760	$ 83,145
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	100%	100%	100%	100%
United States
Disaggregation of Revenue [Line Items]
Revenue	$ 68,392	$ 31,207	$ 120,948	$ 57,383
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	67%	68%	67%	69%
International
Disaggregation of Revenue [Line Items]
Revenue	$ 34,113	$ 14,543	$ 59,812	$ 25,762
International | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of Revenue	33%	32%	33%	31%

Revenue and Contract Balances_2

Revenue and Contract Balances - Disaggregation of Revenue by Type of Customer (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 102,505	$ 45,750	$ 180,760	$ 83,145
% of Revenue	100%	100%	100%	100%
Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 92,785	$ 42,126	$ 164,237	$ 76,238
% of Revenue	91%	92%	91%	92%
Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 9,720	$ 3,624	$ 16,523	$ 6,907
% of Revenue	9%	8%	9%	8%

Revenue and Contract Balances_3

Revenue and Contract Balances - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Disaggregation of Revenue [Line Items]
Unbilled receivables, current	$ 7,100,000		$ 7,100,000		$ 1,500,000
Contract with customer, liability	345,100,000		345,100,000		$ 262,000,000
Contract with customer, liability, revenue recognized	55,400,000	$ 24,500,000	115,400,000	$ 53,600,000
Revenue, remaining performance obligation, amount	444,700,000		444,700,000
Capitalized contract cost, impairment loss	$ 0	$ 0	$ 0	$ 0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-08-01
Disaggregation of Revenue [Line Items]
Revenue, remaining performance obligation, percentage	84%		84%
Revenue, remaining performance obligation, expected timing of satisfaction, period	24 months		24 months
Minimum
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, contract term			1 year
Maximum
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, contract term			3 years

Cash and Cash Equivalents, In_3

Cash and Cash Equivalents, Investments and Fair Value Measurements - Schedule of Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Cash and cash equivalents:
Amortized Cost	$ 269,493	$ 1,669,304
Short-term investments:
Amortized Cost	952,343
Gross Unrealized Gains	41
Gross Unrealized Losses	(2,501)
Estimated Fair Value	949,883
Other liabilities
Amortized Cost	61,264
Gross Unrealized Gains	0
Gross Unrealized Losses	(3,022)
Estimated Fair Value	58,242
Cash
Cash and cash equivalents:
Amortized Cost	34,662
Estimated Fair Value	34,662
Money market funds
Cash and cash equivalents:
Estimated Fair Value		1,641,642
Cash and Cash Equivalents
Cash and cash equivalents:
Amortized Cost	269,499
Gross Unrealized Losses	(6)
Estimated Fair Value	269,493
Level 1 | U.S. Treasury securities
Short-term investments:
Amortized Cost	374,167
Gross Unrealized Gains	37
Gross Unrealized Losses	(746)
Estimated Fair Value	373,458
Level 1 | Money market funds
Cash and cash equivalents:
Amortized Cost	224,854
Estimated Fair Value	224,854	1,641,642
Level 2 | Indemnity Escrow
Other liabilities
Amortized Cost	61,264
Gross Unrealized Gains	0
Gross Unrealized Losses	(3,022)
Estimated Fair Value	58,242
Level 2 | Commercial paper
Short-term investments:
Amortized Cost	452,520
Gross Unrealized Gains	0
Gross Unrealized Losses	(1,278)
Estimated Fair Value	451,242
Level 2 | Corporate notes and bonds
Short-term investments:
Amortized Cost	34,276
Gross Unrealized Gains	0
Gross Unrealized Losses	(168)
Estimated Fair Value	34,108
Level 2 | U.S. agency securities
Short-term investments:
Amortized Cost	91,380
Gross Unrealized Gains	4
Gross Unrealized Losses	(309)
Estimated Fair Value	91,075
Level 2 | Money market funds
Cash and cash equivalents:
Estimated Fair Value		$ 0
Level 2 | Corporate notes and bonds
Cash and cash equivalents:
Amortized Cost	5,001
Gross Unrealized Losses	(2)
Estimated Fair Value	4,999
Level 2 | U.S. agency securities
Cash and cash equivalents:
Amortized Cost	4,982
Gross Unrealized Losses	(4)
Estimated Fair Value	$ 4,978

Cash and Cash Equivalents, In_4

Cash and Cash Equivalents, Investments and Fair Value Measurements - Narratives (Details)	6 Months Ended
	Jul. 31, 2022 USD ($)
Fair Value Disclosures [Abstract]
Debt securities, available-for-sale, unrealized gain (loss)	$ 0

Cash and Cash Equivalents, In_5

Cash and Cash Equivalents, Investments and Fair Value Measurements - Fair Value of Hierarchy (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Short-term investments:
Certificates of deposit	$ 949,883	$ 374
Total assets measured and recorded at fair value		1,642,016
Certificates of deposit
Short-term investments:
Certificates of deposit		374
Money market funds
Cash equivalents:
Estimated Fair Value		1,641,642
Level 1
Short-term investments:
Total assets measured and recorded at fair value		1,641,642
Level 1 | Certificates of deposit
Short-term investments:
Certificates of deposit		0
Level 1 | Money market funds
Cash equivalents:
Estimated Fair Value	$ 224,854	1,641,642
Level 2
Short-term investments:
Total assets measured and recorded at fair value		374
Level 2 | Certificates of deposit
Short-term investments:
Certificates of deposit		374
Level 2 | Money market funds
Cash equivalents:
Estimated Fair Value		0
Level 3
Short-term investments:
Total assets measured and recorded at fair value		0
Level 3 | Certificates of deposit
Short-term investments:
Certificates of deposit		0
Level 3 | Money market funds
Cash equivalents:
Estimated Fair Value		$ 0

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	May 03, 2022	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jan. 31, 2022
Business Acquisition [Line Items]
Stock-based compensation expense		$ 41,001	$ 21,393	$ 34,830	$ 72,631
Restricted cash, non-current		64,207		64,207		$ 2,747
General and administrative
Business Acquisition [Line Items]
Stock-based compensation expense		15,392	$ 7,825	11,693	$ 27,615
Attivo
Business Acquisition [Line Items]
Percentage of voting interests acquired	100%
Stock-based compensation expense	$ 32,900
Assumed options from Attivo acquisition (in shares)	378,828
Assumed options from Attivo acquisition, fair value	$ 11,500
Business combination, compensation related costs	11,400
Restricted cash, non-current	$ 61,000
Release term for Holdback Shares and cash	15 months
Business combination, acquisition related costs		3,300		5,500
Revenue of acquiree since acquisition date				9,300
Loss of acquiree since acquisition date				(9,300)
Attivo | General and administrative
Business Acquisition [Line Items]
Business combination, acquisition related costs		$ 1,000		$ 3,200
Attivo | Restricted common stock
Business Acquisition [Line Items]
Restricted common stock acquired (in shares)	307,396
Restricted common stock acquired, fair value	$ 10,000

Acquisitions - Assets Acquired

Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	May 03, 2022	Jul. 31, 2022	Jan. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 540,308	$ 108,193
Attivo
Business Acquisition [Line Items]
Cash payments for business acquisition	$ 348,917
Assumed options from Attivo acquisition (in shares)	6,032,231
Consideration transferred, equity interests	$ 185,885
Aggregate consideration transferred	534,802
Cash and cash equivalents	8,836
Accounts receivable	4,867
Prepaid expense and other current assets	3,880
Operating lease right-of-use assets	260
Intangible assets	151,900
Accrued liabilities	(4,270)
Accrued payroll and benefits	(1,113)
Operating lease liabilities	(259)
Deferred revenue	(51,746)
Other liabilities	(2,357)
Deferred tax liability	(7,310)
Total identifiable net assets	102,688
Goodwill	432,114
Total purchase consideration	$ 534,802

Acquisitions - Intangible Asset

Acquisitions - Intangible Assets (Details) - Attivo $ in Thousands	May 03, 2022 USD ($)
Business Acquisition [Line Items]
Fair Value	$ 151,900
Customer relationships
Business Acquisition [Line Items]
Fair Value	$ 77,600
Useful Life	10 years
Developed technology
Business Acquisition [Line Items]
Fair Value	$ 63,200
Useful Life	5 years
Backlog
Business Acquisition [Line Items]
Fair Value	$ 11,100
Useful Life	2 years

Acquisitions - Pro Forma (Detai

Acquisitions - Pro Forma (Details) - Attivo - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Business Acquisition [Line Items]
Revenue	$ 102,706	$ 52,741	$ 188,264	$ 96,279
Net loss	$ (100,853)	$ (82,240)	$ (208,032)	$ (154,714)

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	$ 170,988	$ 18,894
Less: total accumulated amortization	(11,566)	(3,342)
Total finite-lived intangible assets, net	159,422	15,552
Indefinite-lived intangible assets - domain names	255	255
Intangible assets, net	159,677	15,807
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	78,700	15,500
Less: total accumulated amortization	(6,447)	(2,165)
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	79,100	1,500
Less: total accumulated amortization	(3,060)	(734)
Backlog
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	11,100	0
Less: total accumulated amortization	(1,397)	0
Non-compete agreements
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	650	650
Less: total accumulated amortization	(319)	(212)
Trademarks
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	150	150
Less: total accumulated amortization	(111)	(73)
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Total finite-lived intangible assets	1,288	1,094
Less: total accumulated amortization	$ (232)	$ (158)

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 7.3	$ 0.9	$ 8	$ 1.6

Intangible Assets - Amortizatio

Intangible Assets - Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 31, 2022	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 14,788
2024	28,532
2025	24,187
2026	22,753
2027	22,753
Thereafter	46,409
Total finite-lived intangible assets, net	$ 159,422	$ 15,552

Stock-Based Compensation - Comp

Stock-Based Compensation - Components of Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 41,001	$ 21,393	$ 34,830	$ 72,631
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	2,399	840	1,223	4,247
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	13,495	8,823	15,962	23,958
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	9,715	3,905	5,952	16,811
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 15,392	$ 7,825	$ 11,693	$ 27,615

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units (Details) - Restricted Stock Units (RSUs)	6 Months Ended
	Jul. 31, 2022 $ / shares shares
Number of Shares
Outstanding, beginning of period (in shares) | shares	1,770,304
Granted (in shares) | shares	7,464,181
Released (in shares) | shares	(317,854)
Forfeited (in shares) | shares	(214,093)
Outstanding, end of period (in shares) | shares	8,702,538
Weighted-Average Grant Date Fair Value
Outstanding, beginning of period (in USD per share) | $ / shares	$ 52.51
Granted (in USD per share) | $ / shares	33.76
Released (in USD per share) | $ / shares	40.74
Forfeited (in USD per share) | $ / shares	42.51
Outstanding, end of period (in USD per share) | $ / shares	$ 37.12

Stock-Based Compensation - Re_2

Stock-Based Compensation - Restricted Stock Units and Stock Options Narrative (Details) $ in Thousands	6 Months Ended
	Jul. 31, 2022 USD ($)
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized amount	$ 289,300
Cost not yet recognized, period for recognition	3 years 4 months 24 days
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized amount	$ 134,100
Cost not yet recognized, period for recognition	2 years 4 months 24 days

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Options (Details) - Stock options - $ / shares	6 Months Ended
	Jul. 31, 2022
Number of Options
Outstanding, beginning of period (in shares)	42,422,473
Granted (in shares)	0
Exercised (in shares)	(3,369,153)
Forfeited (in shares)	(717,964)
Assumed options from Attivo acquisition (in shares)	378,828
Outstanding, end of period (in shares)	38,714,184
Expected to vest (in shares)	38,714,184
Vested and exercisable, Number (in shares)	20,030,216
Weighted-Average Exercise Price
Outstanding, beginning of period (in USD per share)	$ 4.30
Granted (in USD per share)	0
Exercised (in USD per share)	2.49
Forfeited (in USD per share)	5.40
Assumed options from Attivo acquisition (in USD per share)	1.31
Outstanding, end of period (in USD per share)	4.41
Expected to vest (in USD per shares)	4.41
Vested and exercisable, Weighted average (in USD per share)	$ 3.04

Stock-Based Compensation - Mile

Stock-Based Compensation - Milestone Options Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense		$ 41,001	$ 21,393	$ 34,830	$ 72,631
Milestone Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	1,404,605
Vesting percentage	100%
Share-based payment arrangement, expense		900	$ 1,200	1,800	$ 1,200
Cost not yet recognized, amount		$ 14,500		$ 14,500
Cost not yet recognized, period for recognition				4 years 1 month 6 days

Stock-Based Compensation - Perf

Stock-Based Compensation - Performance Share Units Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	May 03, 2022	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 41,001	$ 21,393	$ 34,830	$ 72,631
Attivo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 32,900
Performance share units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		200		200
Cost not yet recognized amount		$ 1,400		$ 1,400
Cost not yet recognized, period for recognition				1 year 4 months 24 days
Performance share units | Attivo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)				71,003
Vesting percentage				100%

Stock-Based Compensation - Re_3

Stock-Based Compensation - Restricted Common Stock Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		6 Months Ended
	Feb. 06, 2021	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense		$ 41,001	$ 21,393	$ 34,830	$ 72,631
Restricted common stock | Scalyr
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)	1,315,099
Shares granted, fair value (in USD per share)	$ 14.59
Award vesting period	2 years
Share-based payment arrangement, expense		2,100	$ 3,100	4,200	$ 5,500
Cost not yet recognized amount		$ 4,400		$ 4,400
Cost not yet recognized, period for recognition				6 months

Stock-Based Compensation - Empl

Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		27 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense	$ 41,001	$ 21,393	$ 34,830	$ 72,631
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense	3,800	$ 1,000	$ 6,500	$ 1,000
Share-based payment arrangement, plan modification, incremental cost	$ 200
ESPP | Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, plan modification, incremental cost					$ 1,300

Stock-Based Compensation - Atti

Stock-Based Compensation - Attivo Acquisition Narrative (Details) - Restricted Stock Units (RSUs)	6 Months Ended
	Jul. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	7,464,181
Attivo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	539,795
Award vesting period	3 years

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation, percent	8.40%	(0.30%)	4.40%	(0.20%)
Discrete tax benefit	$ 9.7		$ 9.7

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable To Common Stockholders - Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Numerator:
Net loss	$ (96,306)	$ (68,163)	$ (186,140)	$ (130,797)
Denominator:
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	277,417,227	120,520,061	273,424,105	82,394,440
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	277,417,227	120,520,061	273,424,105	82,394,440
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share)	$ (0.35)	$ (0.57)	$ (0.68)	$ (1.59)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share)	$ (0.35)	$ (0.57)	$ (0.68)	$ (1.59)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable To Common Stockholders - Anti-dilutive Securities Excluded from the Diluted Calculation (Details) - shares	6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	41,789,945	51,513,450
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	38,316,073	48,385,470
Shares subject to repurchase
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	298,374	63,492
RSUs and PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,343,582	346,483
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	109,217	85,827
Restricted common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	405,620	1,315,099
Contingently issuable shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,317,079	1,317,079

Commitment and Contingencies (D

Commitment and Contingencies (Details) - BlackBerry Litigation	1 Months Ended
	Oct. 31, 2019 arbitration claim lawsuit
Loss Contingencies [Line Items]
Loss contingency, new claims filed, number | claim	9
Loss contingency, number of lawsuits | lawsuit	7
Loss contingency, number of arbitrations | arbitration	2

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2022	Jul. 31, 2021	Jul. 31, 2022	Jul. 31, 2021
Restructuring Cost and Reserve [Line Items]
Defined contribution plan, cost	$ 900,000	$ 0	$ 1,400,000	$ 0
Israel
Restructuring Cost and Reserve [Line Items]
Severance costs	$ 1,000,000	$ 1,000,000	$ 2,000,000	$ 1,800,000